|
Volumn 167, Issue 4, 2011, Pages 331-336
|
Bevacizumab for the treatment of cerebral radionecrosis;Le bévacizumab dans le traitement des radionécroses cérébrales
|
Author keywords
Bevacizumab; Radionecrosis; Side effects
|
Indexed keywords
BEVACIZUMAB;
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
ARTICLE;
BRAIN CANCER;
BRAIN NECROSIS;
CANCER RADIOTHERAPY;
CEREBRAL RADIONECROSIS;
CORNEA ULCER;
DISEASE COURSE;
DRUG WITHDRAWAL;
HUMAN;
LYMPHOCYTOPENIA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
RADIATION NECROSIS;
TRANSIENT ISCHEMIC ATTACK;
TREATMENT FAILURE;
ADENOCARCINOMA;
AGED;
BRAIN DISEASE;
BRAIN TUMOR;
CASE REPORT;
FEMALE;
LUNG TUMOR;
MALE;
MIDDLE AGED;
NECROSIS;
PATHOLOGY;
RADIOSURGERY;
RADIOTHERAPY;
STROKE;
ADENOCARCINOMA;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
BRAIN DISEASES;
BRAIN NEOPLASMS;
CORNEAL ULCER;
FEMALE;
HUMANS;
ISCHEMIC ATTACK, TRANSIENT;
LUNG NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
NECROSIS;
RADIOSURGERY;
RADIOTHERAPY;
STROKE;
|
EID: 79954433150
PISSN: 00353787
EISSN: None
Source Type: Journal
DOI: 10.1016/j.neurol.2010.10.012 Document Type: Article |
Times cited : (9)
|
References (8)
|